Biotoxtech Co. Ltd Cash Flow Conversion Efficiency

Latest as of March 2026: 0.021x

Biotoxtech Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, Biotoxtech Co. Ltd (086040) has a cash flow conversion efficiency ratio of 0.021x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩604.17 Million ≈ $409.43K USD) by net assets (₩29.25 Billion ≈ $19.82 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Biotoxtech Co. Ltd (2011–2025)

Cash flow conversion efficiency of Biotoxtech Co. Ltd from 2011 to 2025. This chart illustrates how Biotoxtech Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 086040 live share price for real-time trading data and today's change.

Biotoxtech Co. Ltd Cash Flow Conversion Ratio Explained

Biotoxtech Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Biotoxtech Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Biotoxtech Co. Ltd ranked by their cash flow conversion efficiency. Also see 086040 company net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Medipharm Labs Corp TO:LABS	-0.022x
Japan Gold Corp V:JG	-0.051x
Orient Precision Industries Inc KQ:065500	-0.015x
Local Bounti Corp NYSE:LOCL	0.034x
Ihlas Gayrimenkul Proje Gelistirme ve Ticaret AS IS:IHLGM	-0.014x
Kisan Telecom Co. Ltd KQ:035460	0.120x
Yandal Resources Ltd AU:YRL	-1.103x
AJ Advance Technology Public Company Limited BK:AJA	-0.019x

Annual Cash Flow Conversion Efficiency for Biotoxtech Co. Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Biotoxtech Co. Ltd from 2011 to 2025. Review cash generation quality of Biotoxtech Co. Ltd to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩31.93 Billion ≈ $21.64 Million	₩6.64 Billion ≈ $4.50 Million	0.208x	+216.99%
2024-12-31	₩40.08 Billion ≈ $27.16 Million	₩-7.12 Billion ≈ $-4.83 Million	-0.178x	+47.23%
2023-12-31	₩48.23 Billion ≈ $32.69 Million	₩-16.24 Billion ≈ $-11.00 Million	-0.337x	-1037.55%
2022-12-31	₩44.23 Billion ≈ $29.98 Million	₩-1.31 Billion ≈ $-887.16K	-0.030x	-128.02%
2021-12-31	₩41.14 Billion ≈ $27.88 Million	₩4.35 Billion ≈ $2.95 Million	0.106x	-22.40%
2020-12-31	₩33.53 Billion ≈ $22.72 Million	₩4.56 Billion ≈ $3.09 Million	0.136x	+184.65%
2019-12-31	₩30.19 Billion ≈ $20.46 Million	₩1.44 Billion ≈ $978.48K	0.048x	-51.17%
2018-12-31	₩31.25 Billion ≈ $21.18 Million	₩3.06 Billion ≈ $2.07 Million	0.098x	-56.77%
2017-12-31	₩26.59 Billion ≈ $18.02 Million	₩6.02 Billion ≈ $4.08 Million	0.227x	+5.24%
2016-12-31	₩24.54 Billion ≈ $16.63 Million	₩5.28 Billion ≈ $3.58 Million	0.215x	+736.12%
2015-12-31	₩23.58 Billion ≈ $15.98 Million	₩-798.17 Million ≈ $-540.91K	-0.034x	+55.89%
2014-12-31	₩26.68 Billion ≈ $18.08 Million	₩-2.05 Billion ≈ $-1.39 Million	-0.077x	-221.95%
2012-12-31	₩25.93 Billion ≈ $17.57 Million	₩1.63 Billion ≈ $1.11 Million	0.063x	-58.32%
2011-12-31	₩21.74 Billion ≈ $14.73 Million	₩3.28 Billion ≈ $2.22 Million	0.151x	--

About Biotoxtech Co. Ltd

KQ:086040 Korea Biotechnology & Medical Research

Market Cap

$21.51 Million

₩31.73 Billion KRW

Market Cap Rank

#24724 Global

#1786 in Korea

Share Price

₩2180.00

Change (1 day)

+2.83%

52-Week Range

₩1983.00 - ₩3925.00

All Time High

₩23000.00